Related Experiment Video

Updated: Sep 25, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins

Yong Zhang1, Xinsheng Gao, Leslie J Saucedo

  • 1Department of Physiology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-9040, USA.

Nature Cell Biology
|May 29, 2003
PubMed

Insights

Mutations in TSC1 or TSC2 genes cause tuberous sclerosis. This study identifies Rheb (Ras homologue enriched in brain) as a direct target of Tsc2 GTPase-activating protein (GAP) activity, revealing a key molecular mechanism.

Area of Science:

  • Molecular biology
  • Genetics
  • Biochemistry

Background:

  • Tuberous sclerosis is a benign tumor syndrome caused by mutations in TSC1 or TSC2 genes.
  • Tsc2 protein contains a domain homologous to GTPase-activating protein (GAP) domains, suggesting a GTPase as its physiological target.

Purpose of the Study:

  • To identify the direct molecular target of Tsc2's GTPase-activating protein (GAP) activity.
  • To elucidate the role of Rheb (Ras homologue enriched in brain) in the TSC tumor suppressor pathway.

Main Methods:

  • In vivo and in vitro assays were used to investigate the interaction between Tsc2 and Rheb.
  • Site-directed mutagenesis was employed to study the function of the Tsc2 GAP domain.

Main Results:

  • Rheb was identified as a direct target of Tsc2 GAP activity.
  • Mutations in the Tsc2 GAP domain impaired Rheb regulation but not Tsc1 complex formation.

Conclusions:

  • Rheb is a direct molecular target of the TSC tumor suppressor complex.
  • This finding provides a mechanistic link between TSC gene mutations and tumor development.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...